Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations - Wikidata - wikimedia - TriplyDB

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

http://www.wikidata.org/entity/Q35029461

about

PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)Integrating multiple immunogenetic data sources for feature extraction and mining somatic hypermutation patterns: the case of "towards analysis" in chronic lymphocytic leukaemia.T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers.Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2.The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia.Chronic lymphocytic leukemia (CLL)-Then and now.Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?Antigen receptor stereotypy in chronic lymphocytic leukemia.The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity.Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations.Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification.ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres.The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements.No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.

P2860

Q26782633-7B297A6B-4D22-4A8C-8566-3DBCF94ACA35 Q31107783-7E849FBA-6A30-47C5-8ED8-BC534C324B81 Q33573774-7305CC76-1E57-435A-8B1A-77907FC20707 Q33804706-4015C7C3-1487-4521-B4DF-94508D73EE1D Q35692395-C7957D2C-C668-489A-BDA8-C0BF6B023D14 Q36261329-038F4B09-1D8C-4C8E-8662-CAF061FD6098 Q37082635-D8A32764-F2EE-419D-826D-62DCE6086792 Q37392612-D10C0C20-C381-4FB0-BF70-91979367FD81 Q38675358-D456C513-E4F0-4464-8F03-0B8AC9B24F40 Q38680890-C0237112-B14A-4E01-876C-017AB4833A12 Q38998146-B629ED0A-8996-4F70-A9C6-EEA1B654E43F Q40929264-439AA09C-4E45-47DB-807C-9014F728E7D6 Q42333289-257D6407-E634-4572-83D0-A645D8DAEECA Q42344564-1A0251F9-9FA3-4FA2-8651-DE747DC3E3E9 Q42384352-2FCAEA7F-1ABA-4D6B-B120-47EE058575A7 Q47430351-E63E6B1E-803F-41B9-A078-6AB3819F9251 Q48187234-EAFA3FD3-15C1-4E91-9C55-6E311F2B22C0 Q50134687-788AAD4A-B3E2-41A6-AF2D-6539A2438985

P2860

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

http://www.wikidata.org/entity/Q35029461

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

@ast

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

@en

type

label

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

@ast

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

@en

prefLabel

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

@ast

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

@en

P1433

Q35029461-E4795AAE-3956-4E4C-AFE5-9C91038FC2C1

P1476

Q35029461-BB8F0E1A-B51B-48C3-A667-B4B84698FCC3

P2093

Q35029461-01670184-B616-4CC9-A9C2-B6B557F5ABBB

Q35029461-0296BA7A-CAE4-4837-A203-C13B4B2BBA66

Q35029461-0937CF92-BD90-410C-9FB3-1D1871F86586

Q35029461-12ACE325-A580-4DEA-A524-9904356A8F73

Q35029461-1478073C-B63B-4443-98A4-4110A0757B9E

Q35029461-20B11CA7-91DF-4376-A483-8A708793D8D5

Q35029461-2533CAF0-BB6D-4F0D-987B-0FC60FA659F5

Q35029461-2977BC95-21EF-469F-9C90-4AA392B389F0

Q35029461-2A905EB8-19C3-48F5-98A3-B0A525B68BE2

Q35029461-3E6D269F-59BC-4B55-89C0-25E7EF91C9C5

P2860

Q35029461-1046B166-A331-440E-A6CF-72054ACED3AC

Q35029461-1B380212-70FC-44F4-9DBE-5AB574D2D20C

Q35029461-23DD8CE1-BB03-4CCA-A5E2-3F47C4ADA99D

Q35029461-46DFC381-3B6C-4508-B388-8BB03E608DEB

Q35029461-59E9BAC9-1284-4119-B859-2FD64CCEC9DE

Q35029461-5A8AE598-8D9F-4511-ADCB-F95046B3A256

Q35029461-5B622847-AEBD-4CAE-ADB1-FBB60AB4146E

Q35029461-639EDFA9-473E-4B6A-A8A1-0186614B89EB

Q35029461-6D9E7A41-1D2D-4A9E-8070-602081A78B8B

Q35029461-85F93D4D-4462-4836-B3C0-CD28CCECA982

P304

Q35029461-23FE1BAE-B775-4441-B474-AF902362E54C

P31

Q35029461-07E307B6-16C7-4129-8700-1EE0B4BE5269

P356

Q35029461-681D745A-D74C-4DA6-90F0-8429810411DB

P407

Q35029461-70E6118F-207E-434C-A82F-EFCE6C718FDC

P433

Q35029461-FC6CC0D7-EFE0-43A7-8F48-5B9776D5FB51

P478

Q35029461-39E8AA35-4691-4E77-A365-D4A1F1C67704

P50

Q35029461-48E1623B-0D12-4918-A40B-696FAB4A504A

Q35029461-4BD7788B-959A-4845-A2C3-825063884794

Q35029461-763A842C-E349-4428-8A92-68700CF8A9C9

Q35029461-8B657133-EE15-4BB6-8928-F2442BCB0AAA

Q35029461-9D7E5E58-77B9-4066-BD32-D55A68A683B9

Q35029461-AD254432-5166-4CEF-820C-8B5DBB991A57

Q35029461-B7AB68F5-1FE8-4815-9396-36EC5722DAEA

Q35029461-D4BF5283-BE90-422B-8027-296984689AB9

Q35029461-D7A2C4DA-6658-4F41-A7BC-CE1E9D1F95C9

Q35029461-DC3AF593-4C71-4B1F-A7C3-7FFE9E7B4AED

P577

Q35029461-7B499AF4-859F-4160-AD06-DD480364B563

P698

Q35029461-D801C6CF-2FEA-4D4B-857C-7AF25303D4FF

P921

Q35029461-AD28B075-88D3-4D81-A11B-19564B2FA327

P932

Q35029461-45023A46-335E-440C-87ED-041C607485B3

P356

BLOOD-2014-09-600874

P1433

P1476

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

@en

P2093

Anastasia Hadzidimitriou

http://www.w3.org/2001/XMLSchema#string

Andreas Agathangelidis

http://www.w3.org/2001/XMLSchema#string

Anne Gardiner

http://www.w3.org/2001/XMLSchema#string

Anton W Langerak

http://www.w3.org/2001/XMLSchema#string

Athina Tsanousa

http://www.w3.org/2001/XMLSchema#string

Charles C Chu

http://www.w3.org/2001/XMLSchema#string

Christian H Geisler

http://www.w3.org/2001/XMLSchema#string

Chrysoula Belessi

http://www.w3.org/2001/XMLSchema#string

David Oscier

http://www.w3.org/2001/XMLSchema#string

Denis Moreno

http://www.w3.org/2001/XMLSchema#string

P2860

Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.

High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors.

Chronic lymphocytic leukemia: revelations from the B-cell receptor.

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.

Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.

Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases.

Stereotyped B-cell receptors in chronic lymphocytic leukemia.

P304

856-859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-09-600874

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Véronique Giudicelli

Marie-Paule Lefranc

Silvio Marco Veronese

Christian Geisler

Florence Nguyen-Khac

Achilles Anagnostopoulos

Karin Ekström Smedby

Chrysoula Belessi

Anastasia Hadzidimitriou

P577

2014-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25634617

http://www.w3.org/2001/XMLSchema#string

P921

P932

4311230

http://www.w3.org/2001/XMLSchema#string